Published in Cell Host Microbe on March 15, 2012
The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell (2012) 4.29
Necroptosis and its role in inflammation. Nature (2015) 3.01
Immune sensing of DNA. Immunity (2013) 2.96
Necroptosis. N Engl J Med (2014) 2.71
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ (2014) 2.66
The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol (2015) 2.36
Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res (2013) 2.26
Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem (2013) 2.24
STING and the innate immune response to nucleic acids in the cytosol. Nat Immunol (2013) 2.23
RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell (2014) 2.06
RIP3: a molecular switch for necrosis and inflammation. Genes Dev (2013) 1.94
RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell (2014) 1.77
Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol (2013) 1.69
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife (2012) 1.53
Regulated cell death in AKI. J Am Soc Nephrol (2014) 1.50
MiR-21 in Extracellular Vesicles Leads to Neurotoxicity via TLR7 Signaling in SIV Neurological Disease. PLoS Pathog (2015) 1.50
Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J Biol Chem (2013) 1.48
TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1. Cell Death Dis (2013) 1.46
RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation. Cell (2017) 1.39
Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense. Proc Natl Acad Sci U S A (2014) 1.38
The two faces of receptor interacting protein kinase-1. Mol Cell (2014) 1.37
Innate immune sensing of HIV-1 by dendritic cells. Cell Host Microbe (2012) 1.35
RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell Death Differ (2014) 1.33
Herpes simplex virus suppresses necroptosis in human cells. Cell Host Microbe (2015) 1.32
Programmed necrosis in the cross talk of cell death and inflammation. Annu Rev Immunol (2014) 1.27
Die another way--non-apoptotic mechanisms of cell death. J Cell Sci (2014) 1.27
DNA damage and the balance between survival and death in cancer biology. Nat Rev Cancer (2015) 1.25
Adenovirus detection by the cGAS/STING/TBK1 DNA sensing cascade. J Virol (2013) 1.22
Viral modulation of programmed necrosis. Curr Opin Virol (2013) 1.20
RIP kinases: key decision makers in cell death and innate immunity. Cell Death Differ (2014) 1.14
Innate immune recognition of DNA: A recent history. Virology (2015) 1.10
Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1. Cell Rep (2015) 1.09
Regulated necrosis: disease relevance and therapeutic opportunities. Nat Rev Drug Discov (2016) 1.09
CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis. Nat Med (2016) 1.09
Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell death. EMBO Rep (2014) 1.07
Staying alive: cell death in antiviral immunity. Mol Cell (2014) 1.06
Programmed necrosis and autophagy in immune function. Immunol Rev (2012) 1.05
Cellular sensing of viral DNA and viral evasion mechanisms. Annu Rev Microbiol (2014) 1.05
New components of the necroptotic pathway. Protein Cell (2012) 1.04
Fueling the flames: Mammalian programmed necrosis in inflammatory diseases. Cold Spring Harb Perspect Biol (2012) 1.03
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis. Cell Death Dis (2015) 1.02
Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages. Proc Natl Acad Sci U S A (2014) 1.01
True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J Immunol (2014) 0.99
Structural basis of signal transduction in the TNF receptor superfamily. Adv Immunol (2013) 0.97
Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol (2016) 0.96
Necrosis-dependent and independent signaling of the RIP kinases in inflammation. Cytokine Growth Factor Rev (2013) 0.95
Reovirus activates a caspase-independent cell death pathway. MBio (2013) 0.95
Dying cells actively regulate adaptive immune responses. Nat Rev Immunol (2017) 0.94
TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis. Oncoimmunology (2012) 0.94
Suppression of RIP3-dependent necroptosis by human cytomegalovirus. J Biol Chem (2015) 0.93
Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS One (2013) 0.93
The transcription factor IRF3 triggers "defensive suicide" necrosis in response to viral and bacterial pathogens. Cell Rep (2013) 0.93
International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease. Pharmacol Rev (2015) 0.92
ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol (2016) 0.92
MLKL forms cation channels. Cell Res (2016) 0.92
Necroptosis: The Trojan horse in cell autonomous antiviral host defense. Virology (2015) 0.91
Programmed cell death as a defence against infection. Nat Rev Immunol (2017) 0.91
Commensal microbiota are required for systemic inflammation triggered by necrotic dendritic cells. Cell Rep (2013) 0.91
RIPK1 inhibits ZBP1-driven necroptosis during development. Nature (2016) 0.91
Live or let die: manipulation of cellular suicide programs by murine cytomegalovirus. Med Microbiol Immunol (2012) 0.90
RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature (2016) 0.90
DNA sensing-independent inhibition of herpes simplex virus 1 replication by DAI/ZBP1. J Virol (2013) 0.89
Manipulation of apoptosis and necroptosis signaling by herpesviruses. Med Microbiol Immunol (2015) 0.88
An outline of necrosome triggers. Cell Mol Life Sci (2016) 0.86
Lymphoid-tissue stromal cells coordinate innate defense to cytomegalovirus. J Virol (2013) 0.86
Rip3 knockdown rescues photoreceptor cell death in blind pde6c zebrafish. Cell Death Differ (2014) 0.85
RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4. Immunity (2016) 0.84
Necroptotic signaling in adaptive and innate immunity. Semin Cell Dev Biol (2014) 0.84
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. Oncoimmunology (2016) 0.84
Recognition of herpes simplex viruses: toll-like receptors and beyond. J Mol Biol (2013) 0.84
HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death. Cell Death Dis (2016) 0.84
Prevention of cellular suicide by cytomegaloviruses. Viruses (2012) 0.84
Grand challenges in cell death and survival: apoptosis vs. necroptosis. Front Cell Dev Biol (2014) 0.83
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death. Cell Death Discov (2017) 0.82
Necroptosis: an alternative cell death program defending against cancer. Biochim Biophys Acta (2016) 0.82
Murine cytomegalovirus virion-associated protein M45 mediates rapid NF-κB activation after infection. J Virol (2014) 0.82
Cytosolic DNA Sensor Upregulation Accompanies DNA Electrotransfer in B16.F10 Melanoma Cells. Mol Ther Nucleic Acids (2016) 0.82
Innate immune responses to DNA viruses. Protein Cell (2013) 0.82
Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination. Vaccines (Basel) (2013) 0.82
Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis. Oncotarget (2016) 0.81
Absence of RIPK3 predicts necroptosis resistance in malignant melanoma. Cell Death Dis (2015) 0.81
Evolutionary link between metazoan RHIM motif and prion-forming domain of fungal heterokaryon incompatibility factor HET-s/HET-s. Sci Rep (2014) 0.81
Phosphatidylserine externalization, "necroptotic bodies" release, and phagocytosis during necroptosis. PLoS Biol (2017) 0.81
Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis. Curr Opin Hematol (2015) 0.80
Death in the fast lane: what's next for necroptosis? FEBS J (2015) 0.80
Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway. Virology (2012) 0.80
Post-translational control of RIPK3 and MLKL mediated necroptotic cell death. F1000Res (2015) 0.80
Inhibition of Theiler's virus-induced apoptosis in infected murine macrophages results in necroptosis. Virus Res (2014) 0.79
Controlled detonation: Evolution of necroptosis in pathogen defense. Immunol Cell Biol (2016) 0.79
HIV-1 protease cleaves the serine-threonine kinases RIPK1 and RIPK2. Retrovirology (2015) 0.79
A motive for killing: effector functions of regulated lytic cell death. Immunol Cell Biol (2016) 0.79
Programmed cell death and its role in inflammation. Mil Med Res (2015) 0.79
Mechanisms of RIPK3-induced inflammation. Immunol Cell Biol (2016) 0.79
Cytomegalovirus immune evasion of myeloid lineage cells. Med Microbiol Immunol (2015) 0.78
Inhibition of p53-dependent, but not p53-independent, cell death by U19 protein from human herpesvirus 6B. PLoS One (2013) 0.78
Diverse mechanisms evolved by DNA viruses to inhibit early host defenses. Crit Rev Biochem Mol Biol (2016) 0.78
Poly-ubiquitination in TNFR1-mediated necroptosis. Cell Mol Life Sci (2016) 0.78
Functional Comparison of Molluscum Contagiosum Virus vFLIP MC159 with Murine Cytomegalovirus M36/vICA and M45/vIRA Proteins. J Virol (2015) 0.78
Necroptosis in acute kidney injury: a shedding light. Cell Death Dis (2016) 0.77
The biochemistry of apoptosis. Nature (2000) 18.91
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature (2007) 13.56
Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell (2009) 11.36
Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell (2009) 11.26
RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science (2009) 9.29
Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol (2008) 9.24
TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature (2008) 6.40
Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature (2011) 6.31
Apoptosis signaling. Annu Rev Biochem (2000) 6.18
RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature (2011) 6.03
cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell (2011) 4.78
The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell (2011) 4.43
Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol (2004) 4.05
Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe (2010) 3.70
Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci U S A (2008) 3.27
BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem (2002) 3.05
Cytoplasmic DNA innate immune pathways. Immunol Rev (2011) 2.84
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 2.80
A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science (2001) 2.70
Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc Natl Acad Sci U S A (2011) 2.64
Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways. Nat Rev Immunol (2011) 2.40
Manipulation of host cell death pathways during microbial infections. Cell Host Microbe (2010) 2.21
Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J Virol (2003) 2.09
Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci U S A (2008) 1.82
Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem (2008) 1.78
DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB. EMBO Rep (2009) 1.72
Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol (2008) 1.66
IFNbeta responses induced by intracellular bacteria or cytosolic DNA in different human cells do not require ZBP1 (DLM-1/DAI). Cell Microbiol (2008) 1.52
Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J Virol (2000) 1.50
The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. J Virol (2004) 1.50
Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1. J Virol (2010) 1.45
Viral subversion of apoptotic enzymes: escape from death row. Annu Rev Microbiol (2008) 1.41
Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. J Virol (2005) 1.39
Cloning of DLM-1, a novel gene that is up-regulated in activated macrophages, using RNA differential display. Gene (1999) 1.34
Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J Virol (2004) 1.21
Multiple death pathways in TNF-treated fibroblasts: RIP3- and RIP1-dependent and independent routes. Cell Res (2011) 1.20
Necrosis is associated with IL-6 production but apoptosis is not. Cell Signal (2005) 1.05
The TLR-independent DNA recognition pathway in murine macrophages: Ligand features and molecular signature. Eur J Immunol (2009) 1.04
A role for DNA-dependent activator of interferon regulatory factor in the recognition of herpes simplex virus type 1 by glial cells. J Neuroinflammation (2011) 1.00
Cytomegaloviruses inhibit Bak- and Bax-mediated apoptosis with two separate viral proteins. Cell Death Differ (2009) 0.98
Activation of the interferon response by human cytomegalovirus occurs via cytoplasmic double-stranded DNA but not glycoprotein B. J Virol (2010) 0.95
Diverse TNFalpha-induced death pathways are enhanced by inhibition of NF-kappaB. Int J Oncol (2007) 0.83
Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science (2002) 7.70
RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature (2011) 6.03
Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe (2010) 3.70
Activation of innate immunity is required for efficient nuclear reprogramming. Cell (2012) 2.99
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med (2003) 2.75
Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J Virol (2005) 2.48
Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem (2013) 2.24
Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat Med (2002) 2.20
Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol (2003) 2.03
Pathogen subversion of cell-intrinsic innate immunity. Nat Immunol (2007) 1.97
Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. J Virol (2004) 1.94
Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem (2008) 1.78
Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner. J Immunol (2012) 1.71
Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors. J Immunol (2008) 1.66
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation (2004) 1.62
Incremental diagnosis method for intelligent wearable sensor systems. IEEE Trans Inf Technol Biomed (2007) 1.62
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation (2006) 1.46
Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol (2003) 1.44
MEDIC: medical embedded device for individualized care. Artif Intell Med (2008) 1.43
Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. J Virol (2005) 1.39
Betaherpesvirus-conserved cytomegalovirus tegument protein ppUL32 (pp150) controls cytoplasmic events during virion maturation. J Virol (2006) 1.30
Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog (2007) 1.29
Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1β via caspase-8 in dendritic cells. J Immunol (2013) 1.28
Viral modulation of programmed necrosis. Curr Opin Virol (2013) 1.20
Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood (2003) 1.19
Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J Virol (2005) 1.16
Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood (2005) 1.15
Control of cytoplasmic maturation events by cytomegalovirus tegument protein pp150. J Virol (2008) 1.15
Viral and host control of cytomegalovirus maturation. Trends Microbiol (2012) 1.15
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation (2006) 1.11
RNA analysis by biosynthetic tagging using 4-thiouracil and uracil phosphoribosyltransferase. Methods Mol Biol (2008) 1.09
Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. J Virol (2009) 1.09
Updated guidelines on the management of cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzumab. Clin Lymphoma Myeloma (2006) 1.09
Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes. Immunity (2012) 1.07
Cytomegalovirus pUL96 is critical for the stability of pp150-associated nucleocapsids. J Virol (2011) 1.05
Protein kinase R mediates intestinal epithelial gene remodeling in response to double-stranded RNA and live rotavirus. J Immunol (2005) 1.02
HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog (2008) 1.00
Gap junctions and connexin hemichannels underpin hemostasis and thrombosis. Circulation (2012) 0.99
True grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity. J Immunol (2014) 0.99
The need and challenges for development of an Epstein-Barr virus vaccine. Vaccine (2013) 0.98
Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J Virol (2004) 0.97
Expression of human CXCR2 in murine neutrophils as a model for assessing cytomegalovirus chemokine vCXCL-1 function in vivo. J Interferon Cytokine Res (2004) 0.96
Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model. BMC Dev Biol (2006) 0.95
Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. J Immunol (2006) 0.94
Transcription of true late (γ2) cytomegalovirus genes requires UL92 function that is conserved among beta- and gammaherpesviruses. J Virol (2013) 0.92
Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation. Blood (2007) 0.92
Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis. J Clin Microbiol (2007) 0.92
Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels. Mol Immunol (2011) 0.92
Cyclosporine inhibits mouse cytomegalovirus infection via a cyclophilin-dependent pathway specifically in neural stem/progenitor cells. J Virol (2007) 0.92
Context-aware sensing of physiological signals. Conf Proc IEEE Eng Med Biol Soc (2007) 0.92
Cytomegalovirus UL91 is essential for transcription of viral true late (γ2) genes. J Virol (2013) 0.91
The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion (2009) 0.91
Feline calicivirus p32, p39 and p30 proteins localize to the endoplasmic reticulum to initiate replication complex formation. J Gen Virol (2009) 0.91
Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. Blood (2002) 0.90
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients. PLoS One (2009) 0.90
Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA. J Virol (2005) 0.89
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. Circulation (2011) 0.89
Episodic sampling: towards energy-efficient patient monitoring with wearable sensors. Conf Proc IEEE Eng Med Biol Soc (2009) 0.89
Changes in coronary arterial dimensions early after cardiac transplantation. Transplantation (2007) 0.89
Manipulation of apoptosis and necroptosis signaling by herpesviruses. Med Microbiol Immunol (2015) 0.88
Proteomic analysis of resting and thrombin-stimulated platelets reveals the translocation and functional relevance of HIP-55 in platelets. Proteomics (2009) 0.83
Enabling large-scale ground-truth acquisition and system evaluation in wireless health. IEEE Trans Biomed Eng (2012) 0.83
PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways. FEBS Lett (2009) 0.82
Repression of human cytomegalovirus major immediate early gene expression by the cellular transcription factor CCAAT displacement protein. Virology (2008) 0.82
Antiviral T cell response triggers cytomegalovirus hepatitis in mice. J Virol (2012) 0.82
Context-driven, prescription-based personal activity classification: methodology, architecture, and end-to-end implementation. IEEE J Biomed Health Inform (2013) 0.81
Inhibition of 2',5'-oligoadenylate synthetase expression and function by the human cytomegalovirus ORF94 gene product. J Virol (2011) 0.80
Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway. Virology (2012) 0.80
Highly acidic C-terminal region of cytomegalovirus pUL96 determines its functions during virus maturation independently of a direct pp150 interaction. J Virol (2014) 0.79
CARER: efficient dynamic sensing for continuous activity monitoring. Conf Proc IEEE Eng Med Biol Soc (2011) 0.79
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus. Transplantation (2008) 0.79
Personalized Multilayer Daily Life Profiling Through Context Enabled Activity Classification and Motion Reconstruction: An Integrated System Approach. IEEE J Biomed Health Inform (2014) 0.79
Measurements of tibial rotation during a simulated pivot shift manoeuvre using a gyroscopic sensor. Knee Surg Sports Traumatol Arthrosc (2014) 0.78
Analysis of protein networks in resting and collagen receptor (GPVI)-stimulated platelet sub-proteomes. Proteomics (2011) 0.78
Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. J Heart Lung Transplant (2007) 0.78
Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis. Virology (2013) 0.77
Integrated inertial sensors and mobile computing for real-time cycling performance guidance via pedaling profile classification. IEEE J Biomed Health Inform (2014) 0.76
Cytomegalovirus and heart transplant atherosclerosis: a likely guilt hidden by weak proofs. Transplantation (2004) 0.75
Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation. Clin Infect Dis (2008) 0.75
Mechanisms modulating immune clearance during human cytomegalovirus latency. Proc Natl Acad Sci U S A (2012) 0.75
Energy-efficient context classification with dynamic sensor control. IEEE Trans Biomed Circuits Syst (2012) 0.75
[Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome]. G Ital Cardiol (Rome) (2007) 0.75
The integration of proteomics and systems approaches to map regulatory mechanisms underpinning platelet function. Proteomics Clin Appl (2013) 0.75
Natural antisense transcripts of UL123 packaged in human cytomegalovirus virions. Arch Virol (2013) 0.75